Skip to main content
Fig. 5 | Cancer Cell International

Fig. 5

From: SNORD63 and SNORD96A as the non-invasive diagnostic biomarkers for clear cell renal cell carcinoma

Fig. 5

The expression of SNORD63 and SNORD96A in formalin fixed paraffin embedding (FFPE), plasma and urinary sediment (US) for early stage ccRCC patients. a The differentially expression of SNORD63 and SNORD96A in FFPE in 32 early stage ccRCC patients compared with adjacent tissues (****Pā€‰<ā€‰0.0001). b The differentially expression of SNORD63 and SNORD96A in plasma in 23 early stage ccRCC patients vs. 40 healthy donors (HD) (ns: no significance, ****Pā€‰<ā€‰0.0001). c The differentially expression of SNORD63 and SNORD96A in US in 39 early ccRCC patients vs. 96 healthy donors (HD) (***Pā€‰<ā€‰0.001, **Pā€‰<ā€‰0.01)

Back to article page